HER2-positive (HER2+) breast cancer is a fast-growing form of invasive breast cancer, one that spreads to other parts of the body. When a person has this type of cancer, tests show high levels of a specific protein, human growth factor receptor 2, which manages how cells grow and divide.
In 2023, the American Cancer Society estimated that invasive breast cancers would affect more than 290,000 women. Invasive breast cancers are cancers that have spread to the surrounding breast tissue. These cancers include:
· Invasive ductal carcinoma
· Lobular breast cancer
Additionally, of those 290,000 cases, between 15% and 20% of those breast cancers will be HER2-positive. Men rarely develop HER2-positive breast cancer.
Similar to many types of breast cancer, HER2-positive breast cancer may not cause obvious symptoms. When it does cause obvious symptoms, you may experience:
· A change in the size, shape, or contour of the breast
· A mass or lump, which may feel as small as a pea
· A lump or thickening in or near the breast or in the underarm that persists through a menstrual cycle
· A change in the look or feel of the skin of the breast. The skin may look dimpled, scaly, or inflamed, and may look reddish or darker than usual.
· A marble-like hardened area under the skin
· A blood-stained or clear fluid discharge from the nipple
HER2-positive breast cancer happens when the HER2 gene mutates, creating the HER2 protein. HER2 proteins or receptors are on all breast cells’ surfaces.
Normally, HER2 proteins manage breast cell growth and repair, making sure cells divide as needed to replace any cells that are damaged or dying. When HER2 genes mutate, they create more copies of themselves, which means more proteins that cause more breast cells to divide and grow and become cancerous tumors.
Many factors can increase the risk of developing HER2 breast cancer, including:
· Having an inherited genetic mutation, such as BRCA1 or BRCA2
· Having a personal history of breast cancer
· Having a condition such as atypical ductal hyperplasia
· Starting your menstrual cycle earlier than usual
· Starting menopause later than usual
· Taking hormone replacement therapy
· Having more than one alcoholic beverage in a day
· History of radiation therapy for conditions, including types of lymphoma
HER2-positive breast cancer causes many complications as it can spread or metastasize. About half of the people with it are diagnosed after the cancer has spread to other areas of the body, including the brain. Metastatic breast cancer in the brain can be life-threatening.
All breast cancers are diagnosed by healthcare providers when they perform breast biopsies. If the biopsies find cancer, a medical pathologist will examine breast tissue cells for signs of HER2 proteins. Laboratory tests can include:
· Immunohistochemistry
· Fluorescence in situ hybridization (FISH)
Since HER2-positive breast cancer is a form of invasive breast cancer, treatments will vary depending on factors such as cancer stage and HER2 status. Treatments may include:
· Targeted therapy
· Chemotherapy
If you would like to learn more about HER2-positive breast cancer, or to learn more about our cancer care program, you can schedule an appointment with an oncologist at our MediSys Health Network Cancer Center by calling (718) 206-6742.
All content of this newsletter is intended for general information purposes only and is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. Please consult a medical professional before adopting any of the suggestions on this page. You must never disregard professional medical advice or delay seeking medical treatment based upon any content of this newsletter. PROMPTLY CONSULT YOUR PHYSICIAN OR CALL 911 IF YOU BELIEVE YOU HAVE A MEDICAL EMERGENCY.









